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Endothelin-1 (ET-l) has been demonstrated to induce hypertrophy in cultured cardiac myocytes. We investigated the production of ET-l in 
the heart of aorta-banded rats in vivo. Seven days after the banding of the abdominal aorta, rats developed asignificant left ventricular hypertrophy. 
The tissue content of mature ET-1 and the level of expression of prepro ET-l mRNA were higher in the left ventricle of aorta-banded rats than 
in those of sham-operated rats. The expression of prepro ET-l mRNA in the right ventricle was not different between the two groups. These tindings 
indicate that the production of ET-l increased in the hypertrophied left ventricle, thereby suggesting the possible involvement of endogenous ET-l 
in the development of cardiac hypertrophy due to pressure overload. 
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1. INTRODUCTION ET-l and the expression of prepro ET-1 mRNA in the 
hypertrophied heart of rats with aortic banding. 
Cardiac hypertrophy, which occurs during a pres- 
sure- and/or volume overload to the heart, is generally 
viewed as a compensatory process that normalizes the 
increased wall stress [l]. However, cardiac hypertrophy 
frequently fails to functionally compensate, and results 
in contractile dysfunction of the myocardium [l]. There- 
fore, cardiac hypertrophy is considered to be an impor- 
tant process in the progression of heart diseases. 
2. MATERIALS AND METHODS 
2.1. Animals and surgical procedures 
The banding of the rat abdominal aorta is a model 
of the cardiac hypertrophy caused by a pressure over- 
load. It has been demonstrated that chronic pressure 
overload to the heart alters the expression of genes for 
contractile elements, growth factors, and proto-onco- 
genes in the heart [2-4]. 
Endothelin-1 (ET-l), originally identified as an endo- 
thelial cell-derived 21 amino acid-residue potent vaso- 
constrictor peptide, shows extensive tissue distribution, 
including the heart [5-71. It has been demonstrated that 
the cardiac myocytes produce ET-1 in culture [8]. ET-1 
shows potent positive inotropic and chronotropic ef- 
fects on heart muscle [9,10]. Furthermore, ET-l has 
been recently demonstrated in cultured ventricular my- 
ocytes to have a potent hypertrophic activity, i.e. an 
increase of cell size, and an activation of the expression 
of contractile protein gene and several proto-oncogenes 
[l 11. However, there is no evidence that the production 
of ET-l alters in the hypertrophied heart. In the present 
study, we investigated both the peptide level of mature 
Nine-week-old male Wistar rats were anesthetized with sodium pen- 
tobarbital (50 mg/kg, i.p.) and the aorta was exposed through a 
midline abdominal incision. The abdominal aorta was constricted 
between the right and left renal arteries, using a 22-gauge needle 
(outside diameter = 0.70 mm) to establish the diameter of the ligature. 
Sham-operated control rats underwent an identical procedure except 
for the ligature. Seven days after surgery, rats were anesthetized with 
sodium pentobarbital. The right carotid artery and the left femoral 
artery were cannulated for measurement of arterial pressure proximal 
and distal to the aortic constriction. After the measurement ofarterial 
pressure, a blood sample was collected from the carotid arterial can- 
nula and rats were sacrificed. The heart was excised and the atria were 
removed. The ventricles were divided into the left ventricle, including 
intraventricular septum, and the right ventricular free wall, and they 
were rinsed with cold Kreb’s-Ringer’s solution, weighed, and quickly 
frozen in liquid nitrogen. Left ventricular hypertrophy was assessed 
by the left ventricular wet weight-to-body weight ratio. 
2.2. Sandwich-enzyme immunoassay (EIA) for ET-I in plasma and the 
heart 
ET-l concentration in plasma and myocardial tissue was deter- 
*Corresponding author. Fax: (81) (298) 533 039. 
mined by a sandwich-EIA as previously described [7,12,13]. The blood 
sample was placed in a chilled tube containing aprotinin (300 kIU/ml) 
and EDTA (2 mg/ml) and plasma was separated from the blood 
sample by centrifugation at 3,000 x g for 15 min at 4°C. The plasma 
was stored at -80°C until used. The left ventricle was homogenized 
with a polytoron homogenizer for 60 s in 10 ~01s. of 1 M acetic acid 
containing 10 &ml pepstatin (Peptide Institute, Osaka, Japan), and 
immediately heated to 1OO’C for 10 min. After chilling, the homoge- 
nate was centrifuged at 23,000 x g for 30 min at 4”C, and the supema- 
tant was stored until used. 
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The plasma and the supematant were subjected to a sandwich-EIA 
for ET-l as previously described, using immobilized mouse monoclo- 
nal antibody AwETN40, which recognizes the N-terminal region of 
ET-l, and peroxidase-labeled rabbit anti-ET-l C-terminal peptide 
(1521) Fab’ [7,12,13]. 
2.3. Northern blot analysis for prepro ET-I mRNA in the heart 
Total RNA was prepared from the myocardium by selective precip- 
itation in 3 M lithium chloride/6 M urea [6]. Total RNA (15 &lane) 
from the left and right ventricles was separated by formamide./l.l% 
agarose gel-electrophoresis and transferred onto a nylon membrane. 
The membrane was prehybridized in a solution containing 5 x SSC, 
5 x Denhardt’s solution, 1% SDS, 50% formamide and 150 &ml 
fragmented salmon sperm DNA, and then hybridized with ‘*P-labeled 
probe in the same solution for 24 h at 42’C. A full-length rat prepro 
ET-1 cDNA (2 kb, EcoRI insert of RrETl-2, see [6]) used as a probe 
was labeled by random priming with [a-‘*P]dCTP. After hybridiza- 
tion, the tilter was washed in 0.1 x SSC/O. 1% SDS at 50°C and autora- 
diographied at -8O’C for 1 week. 
2.4. Data analysis 
Data were expressed as mean + S.E.M. Statistical comparison of 
aorta-banded rats with sham-operated rats was made using Student’s 
t-test for an unpaired value. When a P value was smaller than 0.05, 
the difference in the mean was considered statistically significant. 
3. RESULTS 
Hemodynamic parameters and heart weight-to-body 
weight ratio measured in aorta-banded rats and sham- 
operated rats are summarized in Table I. Mean carotid 
arterial pressure was significantly higher in aorta- 
banded rats than in sham-operated rats. In aorta- 
banded rats, the femoral arterial pressure was 
normotensive. The left ventricular weight-to-body 
weight ratio was significantly higher in aorta-banded 
rats than in sham-operated rats, indicating that aorta- 
banded rats developed a left ventricular hypertrophy. 
The right ventricular weight-to-body weight ratio was 
not significantly different between the two groups. 
We measured the peptide level of ET-1 in the left 
ventricle by a sandwich-EIA specific for ET- 1. The ET- 
1 level in the left ventricle of sham-operated rats was 
199 f 8 pg/g tissue (left panel in Fig. l), which was in 
approximate accordance with previous reports [7,14]. 
The levels of ET-I in the left ventricle were significantly 
higher in aorta-banded rats than in sham-operated rats 
(left panel in Fig. 1). The plasma levels of ET-1 were not 
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Fig. 1. Left ventricular tissue levels (left panel) and plasma levels (right 
panel) of ET-1 in aorta-banded rats (hatched column) and sham- 
operated rats (open column). Each column and bar represents the 
mean +S.E.M. of 6 rats, respectively. *P < 0.05 compared with sham- 
operated rats. 
significantly different between the two groups (right 
panel in Fig. 1). 
The expression of prepro ET-l mRNA in the ventri- 
cles of both aorta-banded and sham-operated rats was 
determined by Northern blot analysis (Fig. 2). The level 
of expression of prepro ET-1 mRNA was markedly 
higher in the left ventricle of aorta-banded rats than that 
of sham-operated rats (left panel in Fig. 2). On the other 
hand, the level of expression of prepro ET-1 mRNA in 
the right ventricular free wall of aorta-banded rats was 
similar to those of sham-operated rats (right panel in 
Fig. 2). 
4. DISCUSSION 
The present study demonstrates that aorta-banded 
rats developed a significant left ventricular hypertro- 
phy. A sandwich-EIA specific for ET-l revealed that the 
peptide levels of ET-1 increased in the hypertrophied 
left ventricle. Furthermore, Northern blot analysis 
showed that the expression of prepro ET-l mRNA was 
Table I 
Hemodynamic parameters and heart weight-to-body weight ratios in rats 7 days after aortic banding and sham operation 
n mCAP mFAP HR LVIBW RVIBW BW Hmt 
(mmHg) @mHg) (beatsfmin) (mg/g) (mg/p) (9) (%) 
Sham 6 114+5 _ 372 + 13 1.91 f 0.03 0.59 + 0.02 355 + 5 52 + 1 
Banding 6 163 + 5*+ 126 + 8 434 zb 13** 2.45 f 0.07** 0.61 f 0.01 326 + 9* 55 f 1 
mCAP, mean carotid arterial pressure; mFAP, mean femoral arterial pressure; HR, heart rate; LV/BW, left ventricular wet weight-to-body weight 
ratio; RV/BW, right ventricular wet weight-to-body weight ratio; SW, body weight; Hmt, hematocrit; n, number of rats; -, not measured. 
Data are expressed as mean + S.E.M. 
*P < 0.05, **P < 0.01 compared with sham-operated rats. 
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Fig. 2. Northern blot analysis for prepro ET-I mRNA in the left or right ventricle in aorta-banded rats (B) and sham-operated rats (S). Lower 
panels show ethidium bromide staining of 18 S ribosomal RNA (rRNA) for a control. The prepro ET-l mRNA (2.3 kb) and 18 S rRNA are indicated 
by arrows Three and 2 independent experiments for the left and right ventricle, respectively, are illustrated. The expression of prepro ET-l mRNA 
was markedly enhanced in the left ventricle, but not in the right ventricle, of aorta-banded rats. Total RNA (15 pg) from these tissues, i.e. left and 
right ventricles, was transferred onto one membrane. 
greatly enhanced in the hy~r~ophied left ventricle but ventricle due to pressure overload. Since ET-1 has been 
not in the right ventricle. Thus, the increase in the tissue reported to induce hypertrophy in cultured cardiac my- 
content of mature ET-1 is probably due to the increase ocytes [ 111, the present findings suggest he possibility 
in the level of prepro ET-1 mRNA. These findings indi- that the up-regulation of ET-I synthesis may be in- 
cate that the production of ET-1 increases in the hy- volved in the development of cardiac hypertrophy due 
pertrophied myocardium due to pressure overload. to pressure overload. 
It has been demonstrated that there is an 8-bp DNA 
sequence that conforms with a consensus of AP-l/Jun- 
binding sites, which is necessary for the phorbol ester- 
induced expression of the prepro ET-1 gene in cultured 
endothelial cells [15,16]. Furthermore, expression of e- 
fos and c-&n proto-on&ogenes has been shown to be 
induced by pressure overload to the myocardium [4]_ 
We can, therefore, consider that pressure overload may 
increase the expression of prepro ET-1 mRNA in the 
heart at least partly via the activation of truns-acting 
transcription factors Fos and Jun. 
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